Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,741,301 papers from all fields of science
Search
Sign In
Create Free Account
Malignant neoplasm of stomach stage IV
Known as:
gastric cancer, metastatic
, metastatic stomach cancer
, Stage IV Gastric Cancer AJCC v7
Expand
Stage IV includes: (Any T, Any N, M1). M1: Distant metastasis. (AJCC 7th ed.)
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
12 relations
Epithelial Cells
Epithelium
Gastric carcinoma stage IV
Gastric mucosa
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
NanoString expression profiling identifies candidate biomarkers of RAD001 response in metastatic gastric cancer
K. Das
,
X. B. Chan
,
+8 authors
P. Tan
ESMO Open
2016
Corpus ID: 10793548
Background Gene expression profiling has contributed greatly to cancer research. However, expression-driven biomarker discovery…
Expand
2015
2015
Neutropenia predicts better prognosis in patients with metastatic gastric cancer on a combined epirubicin, oxaliplatin and 5-fluorouracil regimen
Rujiao Liu
,
Mingzhu Huang
,
+9 authors
Xiaodong Zhu
OncoTarget
2015
Corpus ID: 9717496
Chemotherapy-induced neutropenia (CIN) reportedly indicated better prognosis for some cancers. We retrospectively analyzed 150…
Expand
2012
2012
The validation of matrix metalloproteinase-9 mRNA gene expression as a predictor of outcome in patients with metastatic gastric cancer.
S. Al-Batran
,
C. Pauligk
,
+9 authors
E. Jäger
Annals of Oncology
2012
Corpus ID: 179560
BACKGROUND The prognostic role of matrix metalloproteinase-9 (MMP-9) in metastatic gastric cancer has not been validated…
Expand
2011
2011
Trastuzumab in HER2-Positive Metastatic Gastric Cancer
J. Croxtall
,
K. McKeage
BioDrugs
2011
Corpus ID: 28015937
Withmore than 900 000 new cases annually, gastric cancer is the fourth most prevalent cancer worldwide and, with 700 000 deaths…
Expand
Review
2009
Review
2009
Standard First-Line Chemotherapy for Metastatic Gastric Cancer in Japan Has Met the Global Standard: Evidence From Recent Phase III Trials.
A. Takashima
,
Y. Yamada
,
T. Nakajima
,
Ken Kato
,
T. Hamaguchi
,
Y. Shimada
Gastrointestinal cancer research : GCR
2009
Corpus ID: 40041807
In Japan, standard first-line chemotherapy for metastatic gastric cancer was initially 5-fluorouracil (5-FU) monotherapy. This is…
Expand
Review
2008
Review
2008
Changes of histology and expression of MMP-2 and nm23-H1 in primary and metastatic gastric cancer.
Lin-bo Wang
,
Zhi-nong Jiang
,
M. Fan
,
Chaoyang Xu
,
Wenjun Chen
,
Jian-guo Shen
World Journal of Gastroenterology
2008
Corpus ID: 36461687
AIM To investigate the changes of histology and expression of MMP-2 and nm23-H1 in primary and metastatic gastric cancer…
Expand
Review
2005
Review
2005
Phase II Study of Low-Dose Docetaxel/Fluorouracil/Cisplatin in Metastatic Gastric Carcinoma
Sook Ryun Park
,
J. H. Chun
,
+6 authors
H. Kim
American Journal of Clinical Oncology
2005
Corpus ID: 9308322
Objectives:In several recent reports, docetaxel (75–85 mg/m2) combined with fluorouracil (5-FU) and cisplatin has shown…
Expand
Highly Cited
2002
Highly Cited
2002
De Gramont Schedule is a Very Low Toxic and Effective Regimen in Low Performance Status Patients Affected by Metastatic Gastric Cancer: Preliminary Report
A. Rea
,
G. Caldarola
,
+5 authors
S. Palazzo
Tumori
2002
Corpus ID: 22368733
Summary Treatment of patients affected by metastatic gastric cancer with low performance status (PS) is a very hard choice. It is…
Expand
1996
1996
A phase II study of 5-fluorouracil, leucovorin and cisplatin (FLP) for metastatic gastric cancer.
M. Ychou
,
C. Astre
,
+7 authors
H. Pujol
European Journal of Cancer
1996
Corpus ID: 12677255
1993
1993
Subcutaneous Therapy with Low-Dose Interleukin-2 plus the Neurohormone Melatonin in Metastatic Gastric Cancer Patients with Low Performance Status
P. Lissoni
,
F. Brivio
,
A. Ardizzoia
,
G. Tancini
,
S. Barni
Tumori
1993
Corpus ID: 7049308
Aims and background Patients with disseminated gastric cancer are generally in very bad clinical conditions, which make them not…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE